{
    "Trade/Device Name(s)": [
        "Preciset DAT Plus I",
        "Preciset DAT Plus II",
        "Cfas DAT Qualitative Plus Calibrators"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K060645",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031775",
        "K033306"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKB"
    ],
    "Summary Letter Date": "March 9, 2006",
    "Summary Letter Received Date": "March 10, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3200"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology calibrator"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines",
        "Barbiturates",
        "Benzodiazepines",
        "Cannabinoids",
        "Cocaine",
        "Methadone",
        "Methaqualone",
        "Opiates",
        "Phencyclidine",
        "Propoxyphene"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers (Roche assays)"
    ],
    "Method(s)/Technology(ies)": [
        "Calibrator (drug mixture in urine)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Preciset DAT Plus I, Preciset DAT Plus II, and Cfas DAT Qualitative Plus calibrators for drugs of abuse in human urine.",
    "Indications for Use Summary": "Designed for the calibration of Roche assays for drugs of abuse in human urine on automated clinical chemistry analyzers.",
    "fda_folder": "Toxicology"
}